Bavarian Nordic Receives Accelerated Assessment With EMA For Chikungunya Vaccine Candidate

Bavarian Nordic A/S (BVNKF.PK) announced that CHMP of the European Medicines Agency has granted accelerated assessment for the upcoming Marketing Authorisation Application for CHIKV VLP, an investigational chikungunya vaccine.

Related Keywords

Canada ,London ,City Of ,United Kingdom ,United States ,British , ,Unitedhealth Group ,American Hospital Association ,Standard Chartered Plc ,London Stock Exchange ,Us Consumer Product Safety Commission ,Ikea Us Retail ,Hospital Association ,Change Healthcare ,Product Safety ,Bavarian Nordic ,